NEW YORK (Reuters Health) – Nadroparin, a low-molecular-weight heparin, reduces the incidence of thromboembolic events in ambulatory patients receiving chemotherapy for metastatic or locally advanced solid cancers, an…
NEW YORK (Reuters Health) – In patients with high-risk acute coronary syndromes (ACS) without ST-segment elevation, delaying intervention until the next working day does not appear to pose…
NEW YORK (Reuters Health) – Onset of hyperthermia several days after acute ischemic stroke is strongly associated with greater morbidity and mortality at 3 months, investigators report. A…
NEW YORK (Reuters Health) – In patients with acute coronary syndromes (ACS), ticagrelor appears to be more effective than clopidogrel in reducing the incidence of death from vascular…
NEW YORK (Reuters Health) – The risk of venous thromboembolism (VTE) conferred by oral contraceptives appears to be lowest with the older standbys: contraceptives containing levonorgestrel, progestogen-only pills,…
NEW YORK (Reuters Health) – A new generation of sensitive assays for measuring cardiac troponin I could enhance the diagnostic accuracy for acute myocardial infarction (MI), even early…
NEW YORK (Reuters Health) – Environmental exposure to tobacco smoke – a known risk factor for myocardial infarction and other acute coronary syndromes (ACS) – can also worsen…
NEW YORK (Reuters Health) – Stroke is uncommon after percutaneous coronary intervention (PCI), according to a study of the American College of Cardiology National Cardiovascular Data Registry (NCDR).…
NEW YORK (Reuters Health) – Neoadjuvant hormonal therapy for prostate cancer may increase the risk of death in men with coronary artery disease-induced heart failure or myocardial infarction…
NEW YORK (Reuters Health) – New guidelines released by the American Psychiatric Association and the American College of Obstetricians and Gynecologists indicate that antidepressants and psychotherapy are possible…